IGF2 and mucopolysaccharidosis type 3B: In line with this hypothesis, ICV injection of IGF2-tagged NAGLU has been reported to normalize brain pathology in an MPS IIIB mouse model,56 although therapeutic efficacy upon ICV injection has also been reported for untagged IDS.57